Brief: example

Advancing innovation in accelerated cancer diagnosis

Example AI Ltd's medical imaging models and AI evaluation/assurance tooling are a strong technical fit for a programme focused on clinical validation of early cancer diagnostic technologies — this is precisely the kind of NHS-adjacent, regulated-industry use case the team is built for. As a seed-stage SME at prototype (TRL 4–6), the company meets the SME eligibility requirement and sits in the right readiness band for clinical validation work. The main hurdle is the collaboration-only structure: the founder will need to identify an NHS trust or academic clinical partner to lead or co-lead the consortium, which adds BD effort but also directly supports the goal of winning a first NHS pilot.

Amount

up to £25.4 million

Body

Innovate UK / Office for Life Sciences (OLS)

Who can apply

Open to collaborations only; Lead organisation must be a UK registered business, academic institution, or NHS organisation; Consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding

From the source

Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, is investing up to £25.4 million to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. The competition is open to collaborative projects led by UK registered businesses, academic institutions, or NHS organisations, with at least one UK-registered SME required in each consortium.

Empowering people through data intermediaries

Example AI Ltd's work on LLM agents and AI evaluation tooling in healthcare and regulated industries means data access rights and intermediary friction are directly relevant operational concerns — clearer rules around delegated data subject rights could unlock smoother NHS data pipelines for your prototype. Responding to this consultation is a concrete way to shape legislation that affects your product's data access model, and signals policy engagement to future NHS and public sector pilot partners. However, there is no funding attached and the deadline is well over a year away, so this is a low-urgency, medium-relevance action rather than a priority for your 12-month non-dilutive funding goal.

Body

Department for Digital, Culture, Media and Sport and Department for Science, Innovation and Technology

Who can apply

Open to all — individuals, data intermediaries, data controllers, data processors, and other stakeholders are invited to respond

From the source

The government is consulting on legislative and non-legislative options to remove barriers facing data intermediaries — third-party organisations that act on behalf of individuals to exercise data subject rights. The consultation addresses issues of awareness, friction in third-party data access requests, and legal ambiguity around the roles and delegated rights of data intermediaries.

Notice: Life Sciences Healthcare Goals

The Healthcare Goals programme directly targets diagnosis and monitoring across disease areas (cancer, dementia, mental health) where Example AI Ltd's medical imaging models and LLM agents are highly relevant, and NHS bodies are explicitly named as participants — aligning with your goal of winning a first NHS pilot. However, this is a policy/programme notice rather than an open funding call: there is no deadline, no grant amount, and no direct application mechanism listed, making immediate action difficult. Watch this programme closely for procurement opportunities or SBRI-style calls that emerge from it, as it signals where OLS and DHSC are directing industry partnerships at your prototype TRL stage.

Body

Office for Life Sciences, Department of Health and Social Care, Department for Science, Innovation and Technology

Who can apply

Industry; Academia; Third sector organisations; NHS bodies

From the source

The Healthcare Goals programme applies a Vaccine Taskforce-type approach, bringing together industry, academia, the third sector and the NHS to advance prevention, diagnosis, treatment and monitoring across five disease areas: dementia, cancer, mental health, obesity and addiction. First launched in December 2024, the programme page was last updated in August 2026 to publish programme objectives and KPIs alongside minor updates to individual Goals pages.

• No closing date found in what we read. The source page will say.

Artificial Intelligence: Legislative Proposals

Example AI Ltd's goal of staying ahead of AI safety and data protection requirements makes this parliamentary debate directly relevant as a signal — any legislative framework emerging from this could reshape compliance obligations for LLM agents and medical imaging models in regulated/NHS settings. However, this is a debate, not a funding call or tender, so there is no concrete action to take beyond monitoring outcomes and potentially submitting written evidence if a formal consultation follows. Founders at prototype stage in healthcare AI should track this closely, as early regulatory frameworks often create procurement advantages for companies already aligned with compliance standards.

Body

House of Commons

From the source

A House of Commons Chamber debate took place on 25 June 2025 concerning legislative proposals relating to Artificial Intelligence. The debate considered potential regulatory or statutory frameworks for AI in the UK.

• No closing date found in what we read. The source page will say.
• The angle goes beyond the source wording. Read the page before acting on it.

Artificial Intelligence: Legislation

As a seed-stage AI company in healthcare and regulated industries, Example AI Ltd should monitor this Lords debate closely — the legislative direction on AI regulation directly affects the compliance and assurance landscape your AI evaluation tooling is designed to address. However, this is a parliamentary debate, not a funding call or procurement opportunity, so there is no concrete next step beyond tracking Hansard for signals that could shape your "stay ahead of AI safety and data protection requirements" goal. If a formal consultation or bill emerges from this debate, that would be the moment to engage or submit evidence.

Body

House of Lords

From the source

A Lords Chamber debate on the topic of Artificial Intelligence legislation took place on 21 July 2025. The debate examined legislative approaches to regulating artificial intelligence in the UK.

• No closing date found in what we read. The source page will say.
• The angle goes beyond the source wording. Read the page before acting on it.

Artificial Intelligence: Safeguarding

This Lords debate on AI safeguarding is thematically relevant to Example AI Ltd's goal of staying ahead of AI safety and data protection requirements — particularly given their work on AI evaluation and assurance tooling in healthcare and regulated industries. However, it is a parliamentary debate, not a funding call or procurement opportunity, so there is no direct action to take beyond monitoring the published Hansard transcript for emerging policy signals or regulatory framing that could shape NHS pilot requirements. Founders at prototype stage should treat this as intelligence-gathering only, not a near-term commercial or funding opportunity.

Body

House of Lords

From the source

A Lords Chamber debate on the topic of Artificial Intelligence: Safeguarding took place on 4 November 2025. The session examined issues relating to safeguarding in the context of artificial intelligence.

• No closing date found in what we read. The source page will say.
• The angle goes beyond the source wording. Read the page before acting on it.